Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person EPOR binds EPOR agonists

Class:IdReaction:9709454
_displayNameEPOR binds EPOR agonists
_doReleaseTRUE
_timestamp2022-05-10 17:55:52
authored[InstanceEdit:9724665] Jassal, Bijay, 2021-03-25
compartment[Compartment:876] plasma membrane
[Compartment:984] extracellular region
created[InstanceEdit:9709468] Jassal, Bijay, 2020-12-14
edited[InstanceEdit:9757169] Jassal, Bijay, 2021-10-27
[InstanceEdit:9773839] Matthews, Lisa, 2022-05-10
input[Complex:9006298] EPOR:JAK2:LYN:IRS2 [plasma membrane] [Homo sapiens]
[DefinedSet:9709467] EPOR agonists [extracellular region]
isChimericFALSE
literatureReference[LiteratureReference:9709528] Pure red-cell aplasia and epoetin therapy
[LiteratureReference:9709504] Correction of anemia with epoetin alfa in chronic kidney disease
[LiteratureReference:9709526] An open-label, sequential, dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patients
[LiteratureReference:9709497] Peginesatide to Manage Anemia in Chronic Kidney Disease Patients on Peritoneal Dialysis
[LiteratureReference:9709493] The emerging role of biosimilar epoetins in nephrology in the United States
[LiteratureReference:9709530] History of Erythropoiesis-Stimulating Agents, the Development of Biosimilars, and the Future of Anemia Treatment in Nephrology
modified[InstanceEdit:9709485] Jassal, Bijay, 2020-12-14
[InstanceEdit:9773229] Matthews, Lisa, 2022-05-03
[InstanceEdit:9773839] Matthews, Lisa, 2022-05-10
[InstanceEdit:9773858] Matthews, Lisa, 2022-05-10
[InstanceEdit:9830342] Matthews, Lisa, 2023-03-08
nameEPOR binds EPOR agonists
output[Complex:9709463] EPOR agonists:EPOR:JAK2:LYN:IRS2 [plasma membrane] [Homo sapiens]
releaseDate2022-06-09
reviewed[InstanceEdit:9767610] Huddart, Rachel, 2022-03-01
reviewStatus[ReviewStatus:9821382] five stars
species[Species:48887] Homo sapiens
stableIdentifier[StableIdentifier:9709476] R-HSA-9709454.2
summation[Summation:9709527] Erythropoietin (EPO) is a growth factor produced in the kidn...
(hasEvent)[Pathway:9006335] Signaling by Erythropoietin [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by EPOR binds EPOR agonists (9709454)